| abstract |
The invention relates to a novel therapeutic application of at least one of three factors chosen from G-CSF (Granulocyte Colony Stimulation Factor), GM-CSF (Granulocyte and Macrophage Colony Stimulation Factor) and SCF (Stem Cell Factor). Said factor is used in the preparation of a medicament useful as an adjunct in a reconstruction process for nervous tissue. G-CSF, GM-CSF and SCF are particularly useful in medicaments for the treatment of cerebral vascular events of ischaemic or haemorrhagic nature, cerebral traumas, spinal vascular events of an ischaemic or haemorrhagic nature and spinal trauma. The above are suitable for general administration in human and veterinary medicine. |